Randomized trial · people
Liraglutide: 8.4 kg lost vs 2.8 kg on placebo at 56 weeks
Checked against the paper Randomized trialPublished by PepVault
The takeaway
In a large placebo-controlled trial, liraglutide 3.0 mg with lifestyle counseling led to more weight loss than counseling alone, with stomach side effects as the most common issue.
- Kind
- Randomized trial
- Studied in
- People
- Number studied
- 3731
- Published
- 2015
- Journal
- N Engl J Med
What they tested
Does a daily 3.0 mg liraglutide shot, added to lifestyle counseling, help adults with excess weight lose more weight than placebo over 56 weeks?
How the study was done
A 56-week randomized, double-blind, placebo-controlled trial in 3731 adults without type 2 diabetes, whose body-mass index (a measure of weight for height) was at least 30, or at least 27 alongside dyslipidemia (high blood fats) or high blood pressure. They were split 2:1 between a daily 3.0 mg liraglutide shot (2487 patients) and placebo, a dummy shot (1244 patients), and both groups also received lifestyle counseling.

Model. Individual results vary.
What they found
By week 56, people on liraglutide had lost a mean of 8.4 kg, while those on placebo had lost 2.8 kg. The gap between groups was -5.6 kg, with a 95% confidence interval (the likely range) running from -6.0 to -5.1. On liraglutide, 63.2% lost at least 5% of their starting weight, compared with 27.1% on placebo, and 33.1% versus 10.6% lost more than 10%. Nausea and diarrhea, mostly mild or moderate, were the most common side effects, and serious events occurred in 6.2% of the liraglutide group versus 5.0% of the placebo group.
What it doesn’t show
The trial ran 56 weeks, so it does not show what happens over longer use or after stopping, and it excluded people with type 2 diabetes. Most patients were women (78.5%), and Novo Nordisk funded the study.
The paper
Pi-Sunyer et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med. 2015.
The compound
More studies on Liraglutide
- Liraglutide: 6.4% weight loss vs 15.8% on semaglutide in STEP 8Randomized trial · people · 2022
- Liraglutide plus exercise: 9.5 kg more loss than placebo at 1 yearRandomized trial · people · 2021
- Liraglutide: 13.0% vs 14.9% major cardiovascular events in LEADERRandomized trial · people · 2016
- Every study on Liraglutide
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.